Michael A. Metzger, Director at CTI BIOPHARMA CORP (CTIC), sold 20,121 shares at $6.50 ($131K) on 2022-07-07, disclosed to the SEC on 2022-07-11.
Open-market sale of $131k CTIC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.50 | 9,000 | $59K | 44.7% |
| 2 | $6.51 | 5,900 | $38K | 29.3% |
| 3 | $6.52 | 3,321 | $22K | 16.5% |
| 4 | $6.53 | 400 | $3K | 2.0% |
| 5 | $6.54 | 400 | $3K | 2.0% |
| 6 | $6.55 | 1,100 |
| $7K |
| 5.5% |
| Total | $6.51 avg | 20,121 | $131K | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |